SCA
DPLO

Secor Capital Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Secor Capital Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-99,309
Closed -$1.93M – 648
2018
Q3 		$1.93M Buy
+99,309
New +$2.11M 0.21% 149
2017
Q1 		– Sell
-14,386
Closed -$181K – 649
2016
Q4 		$181K Buy
+14,386
New +$268K 0.02% 462

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Secor Capital Advisors's DPLO Position: Q4 2018 in Review

Secor Capital Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 99,309 shares — an estimated $1.93M sold.

Secor Capital Advisors first reported a position in DPLO in Q4 2016 and held it in 2 quarters. The position peaked at $1.93M in Q3 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Secor Capital Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 99,309 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $1.93M.
  • Secor Capital Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 2 quarters.
  • Secor Capital Advisors's DIPLOMAT PHARMACY, INC. position peaked at $1.93M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.